IPCA gets green signal from US for blood pressure drug
June 4th, 2008 - 7:45 pm ICT by IANS - Send to a friend:
Mumbai, June 4 (IANS) Medical formulations production major Indian Pharmaceuticals Combine Association (IPCA) has received its first approval from US authorities for its blood pressure medicine. Announcing this in a regulatory intimation Wednesday, the company said the US Food and Drugs Administration (USFDA) has given the go-ahead for the manufacturing of Propranolol Hydrochloride tablets.
The total annual sales of this drug, which is also popular among those affected with migraine, last year, touched $24.1 million.
IPCA will manufacture the tablets in 12 mg, 20 mg, 40 mg, 60 mg and 80 mg formulations.
The company will manufacture this formulation for the US healthcare system from its unit in Piparia (Silvassa near Gujarat) with its own active pharmaceutical ingredient (API.)
The company now manufactures and markets its drugs to 100 countries. Its exports contributed to 50 percent of its total income of Rs.10.85 billion in 2007-08.
Related Stories
- Glenmark gets US nod for sale of arthritis drug - March 13, 2008
- Sun Pharma gets US nod for women’s drug - September 12, 2008
- Aurobindo Pharma gets US approval for HIV tablets - September 17, 2008
- US nod to four Zydus Cadilla drugs - May 15, 2008
- Indian firms, Clinton Foundation sign deal on malaria drugs - July 18, 2008
- Now herbal tablets to help quit smoking - July 12, 2008
- Overuse of codeine, oxycodone and barbiturates boosts chronic migraine risk - April 18, 2008
- Man arrested with 70,000 amphetamine pills - February 22, 2008
- US approves Lupin’s anti-depressant drug - June 17, 2008
- Venus Remedies gets nod for latest antibiotic drug - March 3, 2008
- Lupin receives US approval for another drug - July 31, 2008
- Combination drug relieves migraine symptoms if taken early - July 8, 2008
- Orchid gets US FDA approval for its drug - February 20, 2008
- Epilepsy drug may not help avert migraine - February 12, 2008
- Epilepsy drug likely to aggravate birth defect risks - July 22, 2008
- 1 million- - active pharmaceutical ingredient
- - authorities
- - blood pressure drug
- - blood pressure medicine
- - drugs administration
- - gujarat
- - healthcare system
- - hydrochloride
- - indian pharmaceuticals
- - intimation
- - ipca
- - medical formulations
- - medicine
- - migraine
- - propranolol
- - silvassa
- - usfda
Posted in Health Science, |
